MK-3034

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-3034, covering 2017-03-20 to 2017-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113) [Phase 4]

See pricing